The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Levothyroxine 25 micrograms per 5 ml oral solution



Amdipharm LimitedPA1142/029/002

Main Information

Trade NameLevothyroxine 25 micrograms per 5 ml oral solution
Active SubstancesLevothyroxine sodium
Dosage FormOral solution
Licence HolderAmdipharm Limited
Licence NumberPA1142/029/002

Group Information

ATC CodeH03AA01 levothyroxine sodium

Status

License statusAuthorised
Licence Issued06/07/2012
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back